Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aran Research & Development (1982) ROE % Adjusted to Book Value Chart
XTAE:ARAN vs MMM, HON: ROE % Adjusted to Book Value Comparison
For the Conglomerates subindustry, Aran Research & Development (1982)'s ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aran Research & Development (1982) ROE % Adjusted to Book Value vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Aran Research & Development (1982)'s ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Aran Research & Development (1982)'s ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 14.46% mean?
Aran Research & Development (1982) (XTAE:ARAN) has a ROE % Adjusted to Book Value of 14.46% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Aran Research & Development (1982) and its competitors.
Is Aran Research & Development (1982)'s ROE % Adjusted to Book Value too high?
Aran Research & Development (1982)'s current ROE % Adjusted to Book Value is 14.46%. Overall, Aran Research & Development (1982) has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aran Research & Development (1982)'s ROE % Adjusted to Book Value compare to MMM and HON?
Aran Research & Development (1982)'s ROE % Adjusted to Book Value of 14.46% can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Conglomerates company?
A good ROE % Adjusted to Book Value depends on the Conglomerates industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Aran Research & Development (1982) and its competitors. Aran Research & Development (1982)'s current ROE % Adjusted to Book Value is 14.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aran Research & Development (1982) stock overvalued right now?
Based on GuruFocus' analysis, Aran Research & Development (1982) (XTAE:ARAN) is currently considered Fairly Valued. The stock's GF Value™ is ₪37.11, compared to a current price of ₪39.78 — trading 7.2% above its estimated fair value. The current ROE % Adjusted to Book Value is 14.46%. Aran Research & Development (1982)'s overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Aran Research & Development (1982) (XTAE:ARAN), the current ROE % Adjusted to Book Value is 14.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aran Research & Development (1982) (XTAE:ARAN) Overvalued in 2026?
Based on GuruFocus' analysis, Aran Research & Development (1982) stock appears to be overvalued.
The current stock price of ₪39.78 is trading 7.2% above its estimated GF Value™ of ₪37.11.
GuruFocus considers Aran Research & Development (1982) to be Fairly Valued.
Key valuation signals for XTAE:ARAN:
ROE % Adjusted to Book Value: 14.46%
GF Value™: ₪37.11 vs. price of ₪39.78 (7.2% above fair value)
No single metric tells the full story. See the XTAE:ARAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aran Research & Development (1982) Ltd is a product design and development company. It also manufactures equipment for the plastics industry. It develops & supplies products including medical devices, water, defense & HLS, consumer & industrial and injection molds. It also has medical startups which focuses on Cardiovascular, Laparoscopy and Gastrointestinal endoscopy.
78GF Score
Get the complete analysis for XTAE:ARAN
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ARAN has been successfully added to your 
